. 2017 Mar 1;2(1):2381468317697002. doi: 10.1177/2381468317697002

Table 1.

IPV oSIA Strategies Considered in the Context of a Hypothetical cVDPV2 Outbreak in Northwest Nigeria

IPV oSIA Strategy Short Name	Target Population	Age Range in Years	Vaccine, by oSIA Round
IPV oSIA Strategy Short Name	Target Population	Age Range in Years	oSIA1	oSIA2	oSIA3	oSIA4	oSIA5
No IPV	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
No IPV	General population	0–4	—	mOPV2	mOPV2	mOPV2	mOPV2
No IPV but expand oSIA2 through age 9	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
	Outbreak subpopulation	5–9	—	mOPV2	—	—	—
	General population	0–4		mOPV2	mOPV2	mOPV2	mOPV2
	General population	5–9		mOPV2
No IPV but expand oSIA2 through age 14	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
	Outbreak subpopulation	5–14	—	mOPV2	—	—	—
	General population	0–4	—	mOPV2	mOPV2	mOPV2	mOPV2
	General population	5–14	—	mOPV2	—	—	—
IPV added during oSIA1	Outbreak subpopulation	0–4^a	mOPV2 + IPV	mOPV2	mOPV2	mOPV2	mOPV2
IPV added during oSIA1	General population	0–4	—	mOPV2	mOPV2	mOPV2	mOPV2
IPV added during oSIA2	Outbreak subpopulation	0–4^a	mOPV2	mOPV2 + IPV	mOPV2	mOPV2	mOPV2
IPV added during oSIA2	General population	0–4^a	—	mOPV2 + IPV	mOPV2	mOPV2	mOPV2
IPV added during oSIA5	Outbreak subpopulation	0–4^a	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2 + IPV
IPV added during oSIA5	General population	0–4^a	—	mOPV2	mOPV2	mOPV2	mOPV2 + IPV
IPV added during all oSIAs	Outbreak subpopulation	0–4^a	mOPV2 + IPV	mOPV2 + IPV	mOPV2 + IPV	mOPV2 + IPV	mOPV2 + IPV
IPV added during all oSIAs	General population	0–4^a	—	mOPV2 + IPV	mOPV2 + IPV	mOPV2 + IPV	mOPV2 + IPV
IPV 5–9 during oSIA2	Outbreak subpopulation	0–4^a	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
	Outbreak subpopulation	5–9	—	IPV	—	—	—
	General population	0–4	—	mOPV2	mOPV2	mOPV2	mOPV2
	General population	5–9	—	IPV	—	—	—
IPV 5–14 during oSIA2	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
	Outbreak subpopulation	5–14	—	IPV	—	—	—
	General population	0–4	—	mOPV2	mOPV2	mOPV2	mOPV2
	General population	5–14	—	IPV	—	—	—
IPV in general during oSIA1	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
IPV in general during oSIA1	General population	0–4^a	IPV	mOPV2	mOPV2	mOPV2	mOPV2
IPV-only in general during oSIA2	Outbreak subpopulation	0–4	mOPV2	mOPV2	mOPV2	mOPV2	mOPV2
IPV-only in general during oSIA2	General population	0–4^a	—	IPV	mOPV2	mOPV2	mOPV2

Note: IPV = inactivated poliovirus vaccine; oSIA = outbreak response supplemental immunization activity; cVDPV2 = serotype 2 circulating vaccine-derived poliovirus; mOPV2 = serotype 2 monovalent oral poliovirus vaccine.

^a.

IPV target age range excludes age group from 0 through 2 months.